These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 1685741
1. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog. Clark KL, Hilditch A, Robertson MJ, Drew GM. J Hypertens; 1991 Dec; 9(12):1143-50. PubMed ID: 1685741 [Abstract] [Full Text] [Related]
3. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam. Hedge SS, Ricci A, Amenta F, Lokhandwala MF. J Pharmacol Exp Ther; 1989 Dec; 251(3):1237-45. PubMed ID: 2574743 [Abstract] [Full Text] [Related]
4. Do renal tubular dopamine receptors mediate dopamine-induced diuresis in the anesthetized cat? Clark KL, Robertson MJ, Drew GM. J Cardiovasc Pharmacol; 1991 Feb; 17(2):267-76. PubMed ID: 1709232 [Abstract] [Full Text] [Related]
5. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study. Hadengue A, Moreau R, Bacq Y, Gaudin C, Braillon A, Lebrec D. Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029 [Abstract] [Full Text] [Related]
6. Effect of fenoldopam on the acute and subacute nephrotoxicity produced by amphotericin B in the dog. Nichols AJ, Koster PF, Brooks DP, Ruffolo RR. J Pharmacol Exp Ther; 1992 Jan; 260(1):269-74. PubMed ID: 1346161 [Abstract] [Full Text] [Related]
7. Cardiovascular and renal hemodynamic effects of A-68930 in the conscious dog: a comparison with fenoldopam. Christie MI, Smith GW. J Pharmacol Exp Ther; 1994 Feb; 268(2):565-70. PubMed ID: 7906731 [Abstract] [Full Text] [Related]
8. Systemic and pulmonary vascular effects of selective dopamine receptor blockade and stimulation in lambs. Polak MJ, Drummond WH. Pediatr Res; 1993 Feb; 33(2):181-4. PubMed ID: 8094550 [Abstract] [Full Text] [Related]
15. Effects of catechol ring fluorination on cardiovascular and renal activities of fenoldopam enantiomers. Kinter LB, Mann WA, Weinstock J, Ruffolo RR. Chirality; 1994 Feb; 6(5):446-55. PubMed ID: 7915128 [Abstract] [Full Text] [Related]
16. Human vasodilator responses to a dopamine agonist: possible mechanisms. Redman D, Thom SA, Hughes AD, Hasan S, Sever PS. J Hypertens Suppl; 1985 Dec; 3(3):S177-8. PubMed ID: 2908815 [Abstract] [Full Text] [Related]
17. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects. Bughi S, Horton R, Antonipillai I, Manoogian C, Ehrlich L, Nadler J. J Clin Endocrinol Metab; 1989 Dec; 69(6):1116-21. PubMed ID: 2573613 [Abstract] [Full Text] [Related]
18. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat. Le Monnier de Gouville AC, Lawson K, Thiry C, Cavero I. J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375 [Abstract] [Full Text] [Related]
19. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat. Alkadhi KA, Sabouni MH, Ansari AF, Lokhandwala MF. J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213 [Abstract] [Full Text] [Related]
20. Comparison of the effects of dopamine and fenoldopam, a selective dopamine-1 agonist, on parathyroid hormone release in man. Bakris GL, Weber RR, Nelson K, Elliott WJ, Kaplan E, Murphy MB. Miner Electrolyte Metab; 1988 Aug; 14(6):343-6. PubMed ID: 2906737 [Abstract] [Full Text] [Related] Page: [Next] [New Search]